When a patient with chronic kidney disease presents with an acute gout flare, the usual first-line drugs are constrained, so a clear fallback plan helps.
Non-steroidal anti-inflammatories are generally best avoided in significant renal impairment. Colchicine can be used but needs dose reduction and caution with interacting drugs and lower eGFR. For many patients the practical choices are a short course of oral corticosteroid or, for a single accessible joint, intra-articular steroid after excluding septic arthritis. Interleukin-1 blockade is an option for refractory flares or where steroids are problematic, though access varies.
The habit worth keeping is to match the anti-inflammatory to the kidney function and comorbidities in front of you, and to treat the flare promptly rather than waiting, since early treatment shortens it.
- Avoid NSAIDs in significant renal impairment during a gout flare.
- Use colchicine only with dose reduction and attention to interactions and eGFR.
- Favour a short oral steroid course, or intra-articular steroid for a single joint after excluding sepsis.
- Consider interleukin-1 blockade for refractory flares or when steroids are unsuitable.
- Treat the flare early rather than waiting, as prompt treatment shortens it.
Why it matters
The default gout drugs are exactly the ones kidney disease restricts, so a fallback plan prevents undertreated, prolonged flares.
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.
Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for family medicine, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free